These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6777711)

  • 1. Biological evaluation of a TRH analogue with a modified proline residue.
    Dettmar PW; Fortune D; Lynn AG; Metcalf G; Morgan BA
    Neuropharmacology; 1980 Dec; 19(12):1247-8. PubMed ID: 6777711
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological activity of TRH thionalogue and its diastereoisomers.
    Alexandrová M; Strbák V; Herman ZS; Stachura Z; Kruszyński M
    Endocrinol Exp; 1987 Mar; 21(1):43-9. PubMed ID: 3106009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRH analogue with C-terminal thioamide group. Synthesis, receptor binding, TSH-releasing activity and alpha-MSH-releasing activity.
    Kruszyński M; Kupryszewski G; Ragnarsson U; Alexandrova M; Strbak V; Tonon MC; Vaudry H
    Experientia; 1985 Dec; 41(12):1576-7. PubMed ID: 3000815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo TSH releasing activity of two new analogues of TRH.
    Roussel JP; Tapia-Arancibia L; Astier H; Klingler W
    Acta Endocrinol (Copenh); 1987 Feb; 114(2):314-20. PubMed ID: 3103364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRH analogue with C-terminal thioamide group: rapid degradation by plasma and its biological effects.
    Angyal R; Strbák V; Alexandrová M; Kruszyński M
    Endocrinol Exp; 1985 Dec; 19(4):213-9. PubMed ID: 3002750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin-releasing hormone analogue and serotonin interact within the dorsal vagal complex to augment gastric acid secretion.
    McTigue DM; Rogers RC; Stephens RL
    Neurosci Lett; 1992 Sep; 144(1-2):61-4. PubMed ID: 1436715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological and biochemical comparison of thyrotropin releasing hormone (TRH) and di-methyl proline-TRH on pituitary GH3 cells.
    McDermott AM; Wilkin GP; Dickinson SL
    Br J Pharmacol; 1990 Nov; 101(3):615-20. PubMed ID: 1963801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal substance P and galanin attenuate TRH analogue-induced wet-dog shake behaviour.
    Dixon DM; Fone KC; Bennett GW; Marsden CA
    Br J Pharmacol; 1989 Dec; 98 Suppl():829P. PubMed ID: 2482111
    [No Abstract]   [Full Text] [Related]  

  • 9. Modification of the proline residue of TRH enhances biological activity and inhibits degradation.
    Brewster D; Dettmar PW; Lynn AG; Metcalf G; Morgan BA; Rance MJ
    Eur J Pharmacol; 1980 Aug; 66(1):65-71. PubMed ID: 6773784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroendocrine effect of thyroliberin and its analogs].
    Babichev VN; Samsonova VM; Airapetiants MG; Kolomeĭtseva IA; Shvachkin IuP
    Probl Endokrinol (Mosk); 1981; 27(4):35-8. PubMed ID: 6794024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cardiovascular and subjective effects of thyrotropin releasing hormone (TRH) and a stable analogue, dimethyl proline-TRH, in healthy volunteers.
    Coupland NJ; Bailey JE; Glue P; Nutt DJ
    Br J Clin Pharmacol; 1995 Sep; 40(3):223-9. PubMed ID: 8527283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motoneurone excitability after administration of a thyrotrophin releasing hormone analogue.
    Clarke KA; Stirk G
    Br J Pharmacol; 1983 Nov; 80(3):561-5. PubMed ID: 6416344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of thyrotropin-releasing hormone (TRH) and (3Me-His) TRH by brain peptidases studied by high-performance liquid chromatography.
    Griffiths EC; McDermott JR; Smith AI
    Neurosci Lett; 1982 Jan; 28(1):61-5. PubMed ID: 6121306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermogenic effects of thyrotrophin-releasing hormone and its analogues in the rat.
    Griffiths EC; Rothwell NJ; Stock MJ
    Experientia; 1988 Jan; 44(1):40-2. PubMed ID: 3127235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of the phosphinic analogue of thyrotropin releasing hormone.
    Matziari M; Bauer K; Dive V; Yiotakis A
    J Org Chem; 2008 Nov; 73(21):8591-3. PubMed ID: 18826326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRH-Gly, a precursor of TRH, alters GH secretion in acromegaly.
    Mori M; Satoh T; Miyashita K; Yamada M; Murakami M; Iriuchijima T; Ohshima K; Kobayashi I; Kobayashi S
    Life Sci; 1991; 49(14):1031-7. PubMed ID: 1909766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologically stable analogues of TRH with increased neuropharmacological potency.
    Brewster D; Dettmar PW; Metcalf G
    Neuropharmacology; 1981 May; 20(5):497-503. PubMed ID: 6787451
    [No Abstract]   [Full Text] [Related]  

  • 18. Concentrations of thyrotropin-releasing hormone (TRH) and deamido-TRH, and TRH deamidase activity in brain.
    Emerson CH; Vogel W; Currie BL
    Endocrinology; 1980 Aug; 107(2):443-9. PubMed ID: 6771121
    [No Abstract]   [Full Text] [Related]  

  • 19. Conformational analysis of pGlu-His-Amph and pGlu-His-Pro-Amph related to their central nervous system activity.
    Morier E; Fermandjian S; Lhoste JM; Rips R
    Biochimie; 1981 Jun; 63(6):495-505. PubMed ID: 6789894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for interplay between thyrotropin-releasing hormone (TRH) and its structural analogue pGlu-Glu-Pro-NH2 ([Glu2]TRH) in the brain: an in vivo microdialysis study.
    Nguyen V; Zharikova AD; Prokai L
    Neurosci Lett; 2007 Mar; 415(1):64-7. PubMed ID: 17234338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.